The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D01 | Antifungals for dermatological use | |
| 3 | D01A | Antifungals for topical use | |
| 4 | D01AE | Other antifungals for topical use | |
| 5 | D01AE23 | Butenafine |
| Active Ingredient | Description | |
|---|---|---|
| Butenafine |
Butenafine is a benzylamine derivative with a mode of action similar to that of the allylamine class of antifungal drugs. Butenafine HCl is hypothesized to act by inhibiting the epoxidation of squalene, thus blocking the biosynthesis of ergosterol, an essential component of fungal cell membranes. It is indicated for the topical treatment of the dermatologic infection, tinea (pityriasis) versicolor due to M. furfur (formerly P. orbiculare). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| MENTAX Cream | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| TEFIN Suppository | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
